Literature DB >> 2671702

Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.

J K Reddy1, M S Rao.   

Abstract

Peroxisome proliferators are considered as a novel class of hepatocarcinogenic agents because of their non-mutagenic nature and their ability to cause a significant increase in the levels of hydrogen peroxide generating peroxisomal fatty acid beta-oxidation enzyme system in the liver. Sustained increase in the number of peroxisomes in liver has been shown to induce oxidative stress in the liver. Increased levels of H2O2 generation, hydroxyl free-radical formation, lipid peroxidation and accumulation of lipofuscin are found in the livers of rats following long-term treatment with peroxisome proliferators. Recent evidence indicates the presence of 8-hydroxydeoxyguanosine in the liver DNA of rats chronically treated with a peroxisome proliferator suggesting that this may be the basis for carcinogenesis by this class of non-mutagenic carcinogens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671702     DOI: 10.1016/0027-5107(89)90198-x

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  29 in total

Review 1.  The activation of beta-substituted nitrosamines that are carcinogenic to the pancreas.

Authors:  T Lawson; D Nagel; D Rogers
Journal:  Int J Pancreatol       Date:  1991-09

2.  Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase.

Authors:  Courtney G Woods; Amanda M Burns; Akira Maki; Blair U Bradford; Michael L Cunningham; Henry D Connor; Maria B Kadiiska; Ronald P Mason; Jeffrey M Peters; Ivan Rusyn
Journal:  Free Radic Biol Med       Date:  2006-11-03       Impact factor: 7.376

Review 3.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Increased urinary 8-hydroxy-2'-deoxyguanosine levels in workers exposed to di-(2-ethylhexyl) phthalate in a waste plastic recycling site in China.

Authors:  Qian Wang; Li Wang; Xi Chen; Kai Min Rao; Shao You Lu; Sheng Tao Ma; Pu Jiang; Dan Zheng; Shun Qing Xu; Hong Yan Zheng; Jian Shu Wang; Zhi Qiang Yu; Rong Zhang; Yong Tao; Jing Yuan
Journal:  Environ Sci Pollut Res Int       Date:  2011-02-06       Impact factor: 4.223

Review 5.  Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

Authors:  Ivan Rusyn; Jeffrey M Peters; Michael L Cunningham
Journal:  Crit Rev Toxicol       Date:  2006-05       Impact factor: 5.635

6.  Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver.

Authors:  S Bonilla; A Redonnet; C Noël-Suberville; R Groubet; V Pallet; P Higueret
Journal:  J Physiol Biochem       Date:  2001-03       Impact factor: 4.158

7.  In vitro genotoxicity assessment of the synthetic plant growth regulator, 1-naphthaleneacetamide.

Authors:  Ayşe Yavuz Kocaman; Banu Güven
Journal:  Cytotechnology       Date:  2015-02-19       Impact factor: 2.058

Review 8.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

9.  The Role of PPARα Activation in Liver and Muscle.

Authors:  Lena Burri; G Hege Thoresen; Rolf K Berge
Journal:  PPAR Res       Date:  2010-08-18       Impact factor: 4.964

10.  Induction of hepatic microsomal CYP4A activity and of peroxisomal beta-oxidation by two non-steroidal anti-inflammatory drugs.

Authors:  E Rekka; E O Ayalogu; D F Lewis; G G Gibson; C Ioannides
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.